Browsing Tag
abemaciclib
Sermonix to Present Updated Data from ELAINE-2 Clinical Trial of Lasofoxifene in…
COLUMBUS, Ohio, May 31, 2022 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat…
New Drug Halts Recurring Brain Tumor Growth, Says Study
When a non-metastatic brain tumor a meningioma recurs after surgery and radiation treatment, a patient is out of options. No drugs are approved for these aggressive tumors, which…
CKD4/6 Inhibitor in First-Line Treatment for mBC: What Comes Next?
At the virtual San Antonio Breast Cancer Symposium, researchers presented results from research on real-world…